Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrekefen for Early Postoperative Recovery After Benign Gynecological Laparoscopic Surgery
ChiCTR2600128827Phase 4Not yet recruiting
- Sponsor
- Chaohu Hospital of Anhui Medical University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Fibromyoma (LM), ovarian cyst, endometriosis and 3 more comparing Anrekefen intervention group with Normal saline placebo control group (2 arms). Primary endpoint: Total QoR-15 score at 24 hours postoperatively. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
flurbiprofen axetil
03
Conditions
Fibromyoma (LM)ovarian cystendometriosisacute postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600128827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128827.